American Thoracic Society. (2000). Idiopathic pulmonary fibrosis: diagnosis and treatment. American Journal of Respiratory and Critical Care Medicine, 161(2), 646-664.
[2]
Cormier, Y., & Lacasse, Y. (1996). Keys to the diagnosis of hypersensitivity pneumonitis: the role of serum precipitins. Chest, 109(5), 1153-1154.
[3]
Lacasse, Y., Selman, M., Costabel, U., et al. (2009). Clinical diagnosis of hypersensitivity pneumonitis. American Journal of Respiratory and Critical Care Medicine, 180(3), 222-227.
[4]
Patel, A. M., Ryu, J. H., & Reed, C. E. (2001). Hypersensitivity pneumonitis: current concepts and future questions. Journal of Allergy and Clinical Immunology, 108(5), 661-670.
[5]
Selman, M., Lacasse, Y., Pardo, A., & Cormier, Y. (2010). Hypersensitivity pneumonitis: a comprehensive review. Journal of Investig Allergol Clin Immunol, 20(5), 380-395.
[6]
Vasakova, M., Morell, F., Walsh, J. F., Leslie, K. O., & Raghu, G. (2017). Hypersensitivity pneumonitis: perspectives for the future. Chest, 152(1), 165-173.
[7]
World Health Organization. (2022). International Classification of Diseases, 10th Revision (ICD-10). Geneva: WHO.